Gillig; James Ronald

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gillig; James Ronald.The latest application filed is for "7-phenylethylamino-4h-pyrimido[4,5-d][1,3]oxazin-2-one compounds and their use as mutant idh1 inhibitors".

Company Profile

1.6.10

Gillig; James Ronald - Indianapolis IN
Gillig; James Ronald - Indianpolis IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds and their use as mutant IDH1 inhibitors Grant 10,253,041 - Bauer , et al.	2019-04-09
7-phenylethylamino-4h-pyrimido[4,5-d][1,3]oxazin-2-one Compounds And Their Use As Mutant Idh1 Inhibitors App 20180118759 - Bauer; Renato A. ; et al.	2018-05-03
N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor Grant 8,044,090 - Chen , et al. October 25, 2	2011-10-25
N-(2-arylethyl)benzylamines As Antagonists Of The 5-ht6 Receptor App 20090306110 - Chen; Zhaogen ; et al.	2009-12-10
Benzenesulfonic Acid Indol-5-yl Esters As Antagonists Of The 5-ht6 Receptor App 20070135484 - Filla; Sandra Ann ; et al.	2007-06-14
Novel mch receptor antagonists App 20070135485 - Gillig; James Ronald ; et al.	2007-06-14
Benzenesulfonic acid indol-5-yl esters as antagonists of the 5ht.sub.6 receptor Grant 7,230,011 - Filla , et al. June 12, 2	2007-06-12
Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes Grant 7,229,987 - Ammenn , et al. June 12, 2	2007-06-12
N-(2-arylethyl)benzylamines As Antagonists Of The 5-ht6 Receptor App 20070099909 - Chen; Zhaogen ; et al.	2007-05-03
N-(2-Arylethyl) benzylamines as antagonists of the 5-HT.sub.6 receptor Grant 7,157,488 - Chen , et al. January 2, 2	2007-01-02
MCH receptor antagonists Grant 7,132,456 - Gillig , et al. November 7, 2	2006-11-07
Novel mch receptor antagonists App 20060052449 - Gillig; James Ronald ; et al.	2006-03-09
N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor App 20060009511 - Chen; Zhaogen ; et al.	2006-01-12
Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes App 20050272718 - Ammenn, Jochen ; et al.	2005-12-08
N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor App 20040132800 - Chen, Zhaogen ; et al.	2004-07-08
Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor App 20040102481 - Filla, Sandra Ann ; et al.	2004-05-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.